|
This course will provide comprehensive assessment, analysis, and actionable clinical algorithms for the woman with mammographically dense breasts.
There will be representation from all stakeholder perspectives; patients, physicians, breast imagers, epidemiologists, basic researchers, professional and federal organizations,
medical imaging options, and insurers.
1. Legal aspects of Informed Consent (Shared decision making) and its current social, political, and clinical manifestations.
2. A review of the Breast Cancer Consortium Surveillance Conference on Dense Breast: basic and clinical science research. This includes findings and recommen
dations from multiple international work groups concerning the measurement of breast density, associated risk of breast cancer, confounding variables
affecting image masking, and imaging protocols.
3. Current state of Dense Breast Mitigating Technologies (DBMT): Tomosynthesis, Whole Breast Ultrasound, Fast Scan MRI, Molecular Breast Imaging (MBI).
4. The challenge of population based guideline transition to individualized patient protocols.
5. Matching current knowledge (risk factors) and available DBMTs to individual patient algorithms for Breast Cancer Screening - from debate to options for action
both clinically and for future research.
This course is sponsored in part by GE Healthcare.
|
